• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Index insights
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Coronavirus
  • More reports can be found here

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 2004

View Archived Issues

Enrollment completed in phase IIb trial of AOD-9604 for obesity

Read More

Approvable letter for RSR-13

Read More

Urotensin-II receptor antagonist effective against renal ischemia in vivo

Read More

Novel PARP inhibitor attenuates neuronal damage in in vivo models of cerebral ischemia

Read More

Novel compound by Chugai boosts chondrogenesis in vitro and in vivo

Read More

Synthetic N-acylated glucosamines promising for treatment of arthritis

Read More

Anti-IL-13 antibody with potential for the treatment of asthma

Read More

Encysive to retain Thelin marketing rights

Read More

Not approvable letter for proposed Angiomax label amendment

Read More

XL-647 advances into phase I

Read More

GenoMed expands trials into viruses that cause hemorrhagic fever

Read More

Abbott to reacquire rights to trandolapril from Aventis

Read More

Probuphine completes pilot study for opiate addiction

Read More

European MAA submission for Antegren for MS

Read More

Transform collaborates with Abbott to enhance drug development programs

Read More

Cerylid Biosciences completes transaction to acquire Kinacia

Read More

Toyama Chemical commences clinical study with T-817

Read More

Amgen Q1 highlighted by approval of Sensipar

Read More

Guilford updates Q1 progress

Read More

R&D programs at Galen continue to advance during first half of 2004

Read More

Vitamin C disappoints in diabetes study

Read More

KF-19514 ameliorates asthma parameters in vivo

Read More

Rhinovirus infection blocked by lansoprazole

Read More

Brigham and Women's Hospital and Prous Science sign agreement to launch Global Grand Rounds

Read More

BCX-2798 and BCX-2855 show efficacy against human parainfluenza viruses

Read More

The antidiabetic agent BLX-1002 subject of various presentations at ADA

Read More

Retinoid X receptor antagonist improves glucose and lipid metabolism in vivo

Read More

Agonistic antibodies to Epo receptors and their use as antianemic agents

Read More

Anti-GDF-8 antibodies and their use patented by Wyeth and Cambridge Antibody Technology

Read More

Anti-IFN-gamma antibodies developed by scientists at Amgen and Medarex

Read More

Abbott claims three series of compounds for epilepsy, migraine and bipolar disorder

Read More

Amersham patent covers targeted Tc complexes as MRI agents

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 11, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 11, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 8, 2025
  • 3D rendering of a molecular glue mediating the interaction between two proteins

    With surface mimicry, molecular glues shed hairpin need

    BioWorld Science
    Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
  • Incurix describes new c-Myc inhibitors

    BioWorld Science
    Incurix Co. Ltd. has identified Myc proto-oncogene protein (c-Myc) inhibitors reported to be useful for the treatment of cancer.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe